Chordate Medical Holding AB (OSTO:CMH) Price-to-Tangible-Book : 2.91 (As of May. 11, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB Price-to-Tangible-Book?

As of today (2024-05-11), Chordate Medical Holding AB's share price is kr0.064. Chordate Medical Holding AB's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was kr0.02. Hence, Chordate Medical Holding AB's Price to Tangible Book Ratio of today is 2.91.

The historical rank and industry rank for Chordate Medical Holding AB's Price-to-Tangible-Book or its related term are showing as below:

OSTO:CMH' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.77 Med: 35.75 Max: 65.95
Current: 3.2

During the past 9 years, Chordate Medical Holding AB's highest Price to Tangible Book Ratio was 65.95. The lowest was 2.77. And the median was 35.75.

OSTO:CMH's Price-to-Tangible-Book is ranked worse than
55.67% of 697 companies
in the Medical Devices & Instruments industry
Industry Median: 2.77 vs OSTO:CMH: 3.20

A closely related ratio is called PB Ratio. As of today, Chordate Medical Holding AB's share price is kr0.064. Chordate Medical Holding AB's Book Value per Sharefor the quarter that ended in Dec. 2023 was kr0.05. Hence, Chordate Medical Holding AB's P/B Ratio of today is 1.31.

Chordate Medical Holding AB Price-to-Tangible-Book Historical Data

The historical data trend for Chordate Medical Holding AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB Price-to-Tangible-Book Chart

Chordate Medical Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

65.95

5.54

Chordate Medical Holding AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															65.95	4.25	4.89	4.44	5.54

Competitive Comparison of Chordate Medical Holding AB's Price-to-Tangible-Book

For the Medical Devices subindustry, Chordate Medical Holding AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chordate Medical Holding AB's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's Price-to-Tangible-Book falls into.

Chordate Medical Holding AB Price-to-Tangible-Book Calculation

Chordate Medical Holding AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.064	/	0.022
	=	2.91

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Chordate Medical Holding AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordate Medical Holding AB (OSTO:CMH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (OSTO:CMH) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

K1Z:Germany

Address

c/o Regus, Kistagangen 20B, Kista, SWE, 164 40

Website

https://www.chordate.com

Chordate Medical Holding AB is a medical technology company that has developed and patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients who are 18 years old or older. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB (OSTO:CMH) Headlines

No Headlines